Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
VISN PADIOPHARMACEUTICAL PLUVICTO DRUGDepartment of Veterans Affairs$960.2K obligationsEnds Sep 30, 2027
VISN PADIOPHARMACEUTICAL PLUVICTO DRUGDepartment of Veterans Affairs$823.1K obligationsEnds Dec 19, 2026
PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)Department of Veterans Affairs$422.0K obligationsEnds Feb 28, 2025
PLUVICTO RADIOPHARMDepartment of Veterans Affairs$1.1M obligationsEnds Oct 31, 2025
PLUVICTO PROSTATE CANCER TREATMENTDepartment of Veterans Affairs$1.8M obligationsEnds Sep 30, 2024
LUTATHERA (LUTETIUM LU 177 DOTATATE) 3 DOSESDepartment of Veterans Affairs$39.3K obligationsEnds Oct 31, 2023
VA PHOENIX PLUVICTODepartment of Veterans Affairs$664.6K obligationsEnds Dec 31, 2025
PLUVICTO PROSTATE CANCER THERAPY VANCHCSDepartment of Veterans Affairs$1.7M obligationsEnds Sep 30, 2025
ADVANCED ACCELERATOR APPLICATIONS USA, INC.:1308250 [20-000025]Department of Health and Human Services$154.0K obligationsEnds Dec 31, 2019
ADVANCED ACCELERATOR APPLICATIONS USA, INC.:1308250 [20-002108]Department of Health and Human Services$171.5K obligationsEnds Sep 30, 2020
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML.Department of Veterans Affairs$232.6K obligationsEnds Dec 31, 2025
PLUVICTO AND LUTATHERA FY 25Department of Veterans Affairs$3.5M obligationsEnds Oct 31, 2025
PLUVICTO AND LUTATHERADepartment of Veterans Affairs$1.4M obligationsEnds Feb 15, 2026
PLUVICTODepartment of Veterans Affairs$132.8K obligationsEnds Sep 30, 2025
VISN PADIOPHARMACEUTICAL PLUVICTO DRUGDepartment of Veterans Affairs$0 obligationsEnds Dec 19, 2025
NETSPOT GA68 GLADepartment of Veterans Affairs$89.4K obligationsEnds Jan 2, 2026
LUTATHERA & PLUVICTO ISOTOPESDepartment of Veterans Affairs$85.0K obligationsEnds Dec 31, 2025
PLUVICTO AND LUTATHERADepartment of Veterans Affairs$1.2M obligationsEnds Feb 16, 2027
LUTETIUM - PLUVICTO AND LUTATHERADepartment of Veterans Affairs$2.9M obligationsEnds Dec 31, 2025
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML.Department of Veterans Affairs$996.9K obligationsEnds Dec 31, 2026
PLUVICTODepartment of Veterans Affairs$896.1K obligationsEnds Sep 30, 2025
PURCHASE OF MEDICATION ON AN 'AS-NEEDED' BASIS FOR 8 MONTHS.Department of Veterans Affairs$631.4K obligationsEnds Aug 31, 2025
PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)Department of Veterans Affairs$429.2K obligationsEnds Mar 27, 2025
PLUVICTODepartment of Veterans Affairs$616.8K obligationsEnds Sep 30, 2024
PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) EXTENSIONDepartment of Veterans Affairs$166.1K obligationsEnds Jul 31, 2025